Vall d’Hebron Institute of Research (VHIR) has recently signed a collaboration framework agreement with the "http://www.imtm.cz/" Institute of Molecular and Translational Medicine (IMTM), located in Olomouc (Czech Republic), as a part of the actual "http://www.vhir.org/serveis/UAT/presentacioserveis.asp?Idioma=en&mv1=3&mv2=1&mh1=3&mh2=1&mh3=1&a=20&g=3" UAT policy devoted to establish new collaborations with third-parties in order to expand its services portfolio.Through this agreement, VHIR and IMTM are now able to share scientific and technical platforms, allowing VHIR researchers to access the amazing IMTM facilities in a collaborative manner. Also, PhD students from both institutions will benefit from the agreement, since they will be able to spend part of their PhD in the other centre through a shared PhD training program.IMTM is a recently inaugurated translational research centre and is considered one of the most influential research projects carried out in the Czech Republic. It is dedicated to basic and translational biomedical research and encompasses an impressive technological infrastructure including high-throughput platforms with unique technologies. These platforms include Bioinformatics and Biostatistics, Animal Models, Genomics, Proteomics and Cell Biology Core Facilities. The 'star' facility is an impressive high-throughput-screening and high-content-analysis (HTS/HCA) platform, one of the largest academic installations worldwide, based on state-of-the-art robotics and equipped with automatic incubators, liquid handlers for ìl and nl volumes and readers for fluorescence, luminescence, absorbance and ionizing radiation. Wide-field and spinning disk confocal microscopes equipped with specialized image analysis softwares are also included. Crucial part of the robotic system is the automated chemical library, which contains more than 120.000 compounds suitable for a variety of tests.For VHIR’s director, Dr. Joan Comella, this type of agreements between leading international translational institutions seek to promote the use of the most advanced technological tools to further translational research and offers the opportunity of excellent training for our promising young talent. Through international collaborations like this one, he emphasises that “we become more competitive and stronger because this is undoubtedly the way scientific discoveries and innovation advance, and how our research can be translated into applied answers to societal health challenges that can reach society faster and more efficiently”.